Why Biohaven Is a Top Pick

Brian explains Biohaven's degrader platform and its GD‑IgA1 program's potential to change IGAN treatment.

Play episode from 01:47

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!